Related Experiment Videos
Gadolinium neutron capture therapy for brain tumors: a computer study.
J T Masiakowski1, J L Horton, L J Peters
1Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Medical Physics
|September 1, 1992
Summary
This study explored gadolinium neutron capture therapy for brain tumors, finding that two opposing neutron beams can deliver a more uniform dose. Further optimization is needed for effective treatment delivery.
Area of Science:
- Medical Physics
- Radiation Oncology
- Nuclear Medicine
Background:
- Gadolinium neutron capture therapy (GNCT) is a promising modality for brain tumors.
- Utilizing commercially available MRI contrast agents for GNCT requires dose distribution analysis.
- Understanding dose distribution is crucial for optimizing GNCT efficacy and safety.
Purpose of the Study:
- To perform a Monte Carlo computer study on the total dose distribution for gadolinium neutron capture therapy (GNCT) of brain tumors.
- To assess the theoretical feasibility of using MRI contrast agents in GNCT.
- To model dose distribution in a head phantom using specific gadolinium concentrations and neutron irradiation parameters.
Main Methods:
- Monte Carlo simulations were used to calculate the 3D dose distribution from neutrons and prompt gamma emissions.
- Calculations were performed in a spherical head phantom with a central spherical tumor.
- Assumed gadolinium concentrations were 150 µg/g in tumor and 3 µg/g in normal tissue, with 79.9% gadolinium-157 enrichment.
- Irradiation was modeled using a 2-keV monoenergetic epithermal neutron beam (4 cm radius).
Main Results:
- A single neutron beam resulted in inhomogeneous dose distribution within the tumor due to rapid decrease in thermal neutron fluence.
- Two parallel opposed neutron beams improved dose uniformity, delivering 70%-80% of the maximum tumor dose to the normal-malignant tissue interface.
- Achieving an average tumor dose of 500 cGy in 10 minutes requires approximately 8.0 x 10^11 2-keV source neutrons per second.
Conclusions:
- The study demonstrates the theoretical feasibility of using gadolinium-based MRI contrast agents for GNCT of brain tumors.
- Optimizing neutron beam configuration (e.g., using opposed beams) is essential for achieving a more homogeneous dose distribution within the tumor.
- Further research and technological advancements are needed to refine treatment parameters for clinical application.